ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors
August 17, 2021ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of 25-year industry veteran Steven L. Hoerter to its Board of Directors.
Pharma Sources Insight January 2025
